Ontology highlight
ABSTRACT: Rationale & objectives
Glomerular diseases, including minimal change disease, focal segmental glomerulosclerosis, membranous nephropathy, and immunoglobulin A (IgA) nephropathy, share clinical presentations, yet result from multiple biological mechanisms. Challenges to identifying underlying mechanisms, biomarkers, and new therapies include the rarity of each diagnosis and slow progression, often requiring decades to measure the effectiveness of interventions to prevent end-stage kidney disease (ESKD) or death.Study design
Multicenter prospective cohort study.Setting & participants
Cure Glomerulonephropathy (CureGN) will enroll 2,400 children and adults with minimal change disease, focal segmental glomerulosclerosis, membranous nephropathy, or IgA nephropathy (inclu
SUBMITTER: Mariani LH
PROVIDER: S-EPMC6348011 | biostudies-literature | 2019 Feb
REPOSITORIES: biostudies-literature